한글목차

세계의 생체 모방 시스템 시장 규모는 2023년에 1억 892만 달러에 달했습니다.

이 시장은 예측 기간 동안 30.3%의 복합 연간 성장률(CAGR)로 확대될 전망이며, 2030년에는 7억 619만 달러에 달할 것으로 예측되고 있습니다.

북미의 생체 모방 시스템 시장은 2023년에 4,754만 달러에 달했습니다. 이 시장은 예측 기간 동안 31.4%의 복합 연간 성장률(CAGR)로 확대될 전망이며, 2030년까지 3억 2,531만 달러에 달할 것으로 예측됩니다.

아시아태평양의 생체 모방 시스템 시장은 2023년 1,264만 달러에 달했습니다. 이 시장은 예측 기간 동안 30.0%의 복합 연간 성장률(CAGR)로 확대될 전망이며, 2030년까지 8,105만 달러에 이를 것으로 예측됩니다.

유럽의 생체 모방 시스템 시장은 2023년에 4,491만 달러에 달했습니다. 이 시장은 예측 기간 동안 29.3%의 복합 연간 성장률(CAGR)로 확대될 전망이며, 2030년까지 2억 7,672만 달러에 달할 것으로 예측됩니다.

생체 모방 시스템의 세계의 주요 기업으로는 Emulate, Mimetas, InSphero, TissUse, CN Bio, Hesperos, Valo Health(TARA Biosystems), TNO, AxoSim, Newcells Biotech 등이 있습니다. 2023년에는 세계의 5대 기업이 매출액에서 약 50.59%의 점유율을 차지하고 있습니다.

이 보고서는 세계의 생체 모방 시스템 시장을 조사했으며, 시장 개요와 함께 유형별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 시장 개요

• 생체 모방 시스템의 제품 소개
• 세계의 생체 모방 시스템 시장 규모 예측(2019년-2030년)
• 생체 모방 시스템 시장 동향과 촉진요인
• 정부별 업계에의 정책 지원
• 관련 기술의 비교
• 전제와 제한
• 조사 목적
• 대상 연도

제2장 기업에 의한 경쟁 분석

제3장 유형별 세분화

• 인트로덕션(유형별)
• 세계의 생체 모방 시스템의 판매액(유형별)

제4장 최종 사용자별 세분화

• 소개(최종사용자별)
• 세계의 생체 모방 시스템의 판매액(최종사용자별)

제5장 지역별 세분화

• 생체 모방 시스템의 판매액(지역별)
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제6장 주요국, 지역별 세분화

• 주요 국가/지역의 생체 모방 시스템의 매출 성장 동향(2019년vs2023년vs2030년)
• 주요국가/지역에 있어서의 생체 모방 시스템의 매출액(2019년-2030년)
• 미국
• 유럽
• 중국
• 일본
• 동남아시아
• 프랑스
• 영국

제7장 기업 프로파일

• Emulate
• Mimetas
• InSphero
• TissUse
• CN Bio
• Hesperos
• Valo Health(TARA Biosystems)
• TNO
• AxoSim
• Newcells Biotech
• Nortis
• Netri
• Draper Laboratory
• Beijing Daxiang Biotech
• Altis Biosystems
• Cherry Biotech
• Bi/ond
• Obatala Sciences
• Ananda Devices
• ImmuONE
• React4life
• AlveoliX
• BiomimX
• Aracari Bio
• StemPharm
• SynVivo

제8장 산업 체인 분석

제9장 조사 결과와 결론

제10장 부록

영문목차

The global market for Microphysiological System was estimated to be worth US$ 108.92 million in 2023 and is forecast to a readjusted size of US$ 706.19 million by 2030 with a CAGR of 30.3% during the forecast period 2024-2030.

North American market for Microphysiological System was valued at $ 47.54 million in 2023 and will reach $ 325.31 million by 2030, at a CAGR of 31.4 % during the forecast period of 2024 through 2030.

Asia-Pacific market for Microphysiological System was valued at $ 12.64 million in 2023 and will reach $ 81.05 million by 2030, at a CAGR of 30.0 % during the forecast period of 2024 through 2030.

Europe market for Microphysiological System was valued at $ 44.91 million in 2023 and will reach $ 276.72 million by 2030, at a CAGR of 29.3 % during the forecast period of 2024 through 2030.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Hesperos, Valo Health (TARA Biosystems), TNO, AxoSim and Newcells Biotech, etc. In 2023, the global five largest players hold a share approximately 50.59 % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Microphysiological System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microphysiological System by region & country, by Type, and by End User.

The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.

Market Segmentation

By Company

• Emulate
• Mimetas
• InSphero
• TissUse
• CN Bio
• Hesperos
• Valo Health (TARA Biosystems)
• TNO
• AxoSim
• Newcells Biotech
• Nortis
• Netri
• Draper Laboratory
• Beijing Daxiang Biotech
• Altis Biosystems
• Cherry Biotech
• Bi/ond
• Obatala Sciences
• Ananda Devices
• ImmuONE
• React4life
• AlveoliX
• BiomimX
• Aracari Bio
• StemPharm
• SynVivo

Segment by Type

• Human Organ and Tissue Models
• Disease Models
• Non-Human Species Models

Segment by End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Region

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Europe
• Germany
• France
• U.K.
• Italy
• Netherlands
• Nordic Countries
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Microphysiological System Product Introduction
• 1.2 Global Microphysiological System Market Size Forecast (2019-2030)
• 1.3 Microphysiological System Market Trends & Drivers
  • 1.3.1 Microphysiological System Industry Trends
  • 1.3.2 Microphysiological System Market Drivers & Opportunity
  • 1.3.3 Microphysiological System Market Challenges
  • 1.3.4 Microphysiological System Market Restraints
• 1.4 Government Policy Support for The Industry
• 1.5 Comparison of Related Technologies
• 1.6 Assumptions and Limitations
• 1.7 Study Objectives
• 1.8 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Microphysiological System Players Revenue Ranking (2023)
• 2.2 Global Microphysiological System Revenue by Company (2019-2024)
• 2.3 Key Companies Microphysiological System Headquarters and Sales Area
• 2.4 Key Companies Microphysiological System Product Offered
• 2.5 Establish Date of Global Key Microphysiological System Companies
• 2.6 Microphysiological System Market Competitive Analysis
  • 2.6.1 Microphysiological System Market Concentration Rate (2019-2024)
  • 2.6.2 Global 5 and 10 Largest Companies by Microphysiological System Revenue in 2023
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Human Organ and Tissue Models
  • 3.1.2 Disease Models
  • 3.1.3 Non-Human Species Models
• 3.2 Global Microphysiological System Sales Value by Type
  • 3.2.1 Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030)
  • 3.2.2 Global Microphysiological System Sales Value, by Type (2019-2030)
  • 3.2.3 Global Microphysiological System Sales Value, by Type (%) (2019-2030)

4 Segmentation by End User

• 4.1 Introduction by End User
  • 4.1.1 Pharmaceutical & Biotechnology Companies
  • 4.1.2 Academic & Research Institutes
  • 4.1.3 Others
• 4.2 Global Microphysiological System Sales Value by End User
  • 4.2.1 Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030)
  • 4.2.2 Global Microphysiological System Sales Value, by End User (2019-2030)
  • 4.2.3 Global Microphysiological System Sales Value, by End User (%) (2019-2030)

5 Segmentation by Region

• 5.1 Global Microphysiological System Sales Value by Region
  • 5.1.1 Global Microphysiological System Sales Value by Region: 2019 VS 2023 VS 2030
  • 5.1.2 Global Microphysiological System Sales Value by Region (2019-2024)
  • 5.1.3 Global Microphysiological System Sales Value by Region (2025-2030)
  • 5.1.4 Global Microphysiological System Sales Value by Region (%), (2019-2030)
• 5.2 North America
  • 5.2.1 North America Microphysiological System Sales Value, 2019-2030
  • 5.2.2 North America Microphysiological System Sales Value by Country (%), 2023 VS 2030
• 5.3 Europe
  • 5.3.1 Europe Microphysiological System Sales Value, 2019-2030
  • 5.3.2 Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Microphysiological System Sales Value, 2019-2030
  • 5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030
• 5.5 Latin America
  • 5.5.1 Latin America Microphysiological System Sales Value, 2019-2030
  • 5.5.2 Latin America Microphysiological System Sales Value by Country (%), 2023 VS 2030
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Microphysiological System Sales Value, 2019-2030
  • 5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2019 VS 2023 VS 2030
• 6.2 Key Countries/Regions Microphysiological System Sales Value, 2019-2030
• 6.3 United States
  • 6.3.1 United States Microphysiological System Sales Value, 2019-2030
  • 6.3.2 United States Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 United States Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe Microphysiological System Sales Value, 2019-2030
  • 6.4.2 Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.5 China
  • 6.5.1 China Microphysiological System Sales Value, 2019-2030
  • 6.5.2 China Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.5.3 China Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.6 Japan
  • 6.6.1 Japan Microphysiological System Sales Value, 2019-2030
  • 6.6.2 Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 Japan Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.7 Southeast Asia
  • 6.7.1 Southeast Asia Microphysiological System Sales Value, 2019-2030
  • 6.7.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 Southeast Asia Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.8 France
  • 6.8.1 France Microphysiological System Sales Value, 2019-2030
  • 6.8.2 France Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.8.3 France Microphysiological System Sales Value by End User, 2023 VS 2030
• 6.9 UK
  • 6.9.1 UK Microphysiological System Sales Value, 2019-2030
  • 6.9.2 UK Microphysiological System Sales Value by Type (%), 2023 VS 2030
  • 6.9.3 UK Microphysiological System Sales Value by End User, 2023 VS 2030

7 Company Profiles

• 7.1 Emulate
  • 7.1.1 Emulate Profile
  • 7.1.2 Emulate Main Business
  • 7.1.3 Emulate Microphysiological System Products, Services and Solutions
  • 7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.2 Mimetas
  • 7.2.1 Mimetas Profile
  • 7.2.2 Mimetas Main Business
  • 7.2.3 Mimetas Microphysiological System Products, Services and Solutions
  • 7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.2.5 Mimetas Recent Developments
• 7.3 InSphero
  • 7.3.1 InSphero Profile
  • 7.3.2 InSphero Main Business
  • 7.3.3 InSphero Microphysiological System Products, Services and Solutions
  • 7.3.4 InSphero Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.3.5 InSphero Recent Developments
• 7.4 TissUse
  • 7.4.1 TissUse Profile
  • 7.4.2 TissUse Main Business
  • 7.4.3 TissUse Microphysiological System Products, Services and Solutions
  • 7.4.4 TissUse Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.5 CN Bio
  • 7.5.1 CN Bio Profile
  • 7.5.2 CN Bio Main Business
  • 7.5.3 CN Bio Microphysiological System Products, Services and Solutions
  • 7.5.4 CN Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.5.5 CN Bio Recent Developments
• 7.6 Hesperos
  • 7.6.1 Hesperos Profile
  • 7.6.2 Hesperos Main Business
  • 7.6.3 Hesperos Microphysiological System Products, Services and Solutions
  • 7.6.4 Hesperos Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.7 Valo Health (TARA Biosystems)
  • 7.7.1 Valo Health (TARA Biosystems) Profile
  • 7.7.2 Valo Health (TARA Biosystems) Main Business
  • 7.7.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions
  • 7.7.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.7.5 Valo Health (TARA Biosystems) Recent Developments
• 7.8 TNO
  • 7.8.1 TNO Profile
  • 7.8.2 TNO Main Business
  • 7.8.3 TNO Microphysiological System Products, Services and Solutions
  • 7.8.4 TNO Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.9 AxoSim
  • 7.9.1 AxoSim Profile
  • 7.9.2 AxoSim Main Business
  • 7.9.3 AxoSim Microphysiological System Products, Services and Solutions
  • 7.9.4 AxoSim Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.9.5 AxoSim Recent Developments
• 7.10 Newcells Biotech
  • 7.10.1 Newcells Biotech Profile
  • 7.10.2 Newcells Biotech Main Business
  • 7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions
  • 7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.10.5 Newcells Biotech Recent Developments
• 7.11 Nortis
  • 7.11.1 Nortis Profile
  • 7.11.2 Nortis Main Business
  • 7.11.3 Nortis Microphysiological System Products, Services and Solutions
  • 7.11.4 Nortis Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.11.5 Nortis Recent Developments
• 7.12 Netri
  • 7.12.1 Netri Profile
  • 7.12.2 Netri Main Business
  • 7.12.3 Netri Microphysiological System Products, Services and Solutions
  • 7.12.4 Netri Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.12.5 Netri Recent Developments
• 7.13 Draper Laboratory
  • 7.13.1 Draper Laboratory Profile
  • 7.13.2 Draper Laboratory Main Business
  • 7.13.3 Draper Laboratory Microphysiological System Products, Services and Solutions
  • 7.13.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.14 Beijing Daxiang Biotech
  • 7.14.1 Beijing Daxiang Biotech Profile
  • 7.14.2 Beijing Daxiang Biotech Main Business
  • 7.14.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions
  • 7.14.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.15 Altis Biosystems
  • 7.15.1 Altis Biosystems Profile
  • 7.15.2 Altis Biosystems Main Business
  • 7.15.3 Altis Biosystems Microphysiological System Products, Services and Solutions
  • 7.15.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.15.5 Altis Biosystems Recent Developments
• 7.16 Cherry Biotech
  • 7.16.1 Cherry Biotech Profile
  • 7.16.2 Cherry Biotech Main Business
  • 7.16.3 Cherry Biotech Microphysiological System Products, Services and Solutions
  • 7.16.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.17 Bi/ond
  • 7.17.1 Bi/ond Profile
  • 7.17.2 Bi/ond Main Business
  • 7.17.3 Bi/ond Microphysiological System Products, Services and Solutions
  • 7.17.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.18 Obatala Sciences
  • 7.18.1 Obatala Sciences Profile
  • 7.18.2 Obatala Sciences Main Business
  • 7.18.3 Obatala Sciences Microphysiological System Products, Services and Solutions
  • 7.18.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.19 Ananda Devices
  • 7.19.1 Ananda Devices Profile
  • 7.19.2 Ananda Devices Main Business
  • 7.19.3 Ananda Devices Microphysiological System Products, Services and Solutions
  • 7.19.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.19.5 Ananda Devices Recent Developments
• 7.20 ImmuONE
  • 7.20.1 ImmuONE Profile
  • 7.20.2 ImmuONE Main Business
  • 7.20.3 ImmuONE Microphysiological System Products, Services and Solutions
  • 7.20.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2019-2024)
  • 7.20.5 ImmuONE Recent Developments
• 7.21 React4life
  • 7.21.1 React4life Profile
  • 7.21.2 React4life Main Business
  • 7.21.3 React4life Microphysiological System Products, Services and Solutions
  • 7.21.4 React4life Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.22 AlveoliX
  • 7.22.1 AlveoliX Profile
  • 7.22.2 AlveoliX Main Business
  • 7.22.3 AlveoliX Microphysiological System Products, Services and Solutions
  • 7.22.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.23 BiomimX
  • 7.23.1 BiomimX Profile
  • 7.23.2 BiomimX Main Business
  • 7.23.3 BiomimX Microphysiological System Products, Services and Solutions
  • 7.23.4 BiomimX Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.24 Aracari Bio
  • 7.24.1 Aracari Bio Profile
  • 7.24.2 Aracari Bio Main Business
  • 7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions
  • 7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.25 StemPharm
  • 7.25.1 StemPharm Profile
  • 7.25.2 StemPharm Main Business
  • 7.25.3 StemPharm Microphysiological System Products, Services and Solutions
  • 7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2019-2024)
• 7.26 SynVivo
  • 7.26.1 SynVivo Profile
  • 7.26.2 SynVivo Main Business
  • 7.26.3 SynVivo Microphysiological System Products, Services and Solutions
  • 7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2019-2024)

8 Industry Chain Analysis

• 8.1 Microphysiological System Industrial Chain
• 8.2 Whole Industry Chain Map
• 8.3 Microphysiological System Upstream Analysis
  • 8.3.1 Upstream Analysis
  • 8.3.2 Raw Materials Key Suppliers
  • 8.3.3 Manufacturing Cost Structure
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Main Business Model
• 8.6 Sales Model and Sales Channels

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer